Effects of <i>Cordyceps cicadae</i> Polysaccharide on Gut Microbiota, the Intestinal Mucosal Barrier, and Inflammation in Diabetic Mice

<b>Background:</b> Polysaccharides produced by the edible fungus <i>Cordyceps cicadae</i> can regulate blood sugar levels and may represent a suitable candidate for the treatment of diabetes and its complications. However, there is limited information available about the mech...

Full description

Saved in:
Bibliographic Details
Main Authors: Lijia Sun, Huaibo Yuan, Huiqing Ma, Yani Wang
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/15/1/8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587984775413760
author Lijia Sun
Huaibo Yuan
Huiqing Ma
Yani Wang
author_facet Lijia Sun
Huaibo Yuan
Huiqing Ma
Yani Wang
author_sort Lijia Sun
collection DOAJ
description <b>Background:</b> Polysaccharides produced by the edible fungus <i>Cordyceps cicadae</i> can regulate blood sugar levels and may represent a suitable candidate for the treatment of diabetes and its complications. However, there is limited information available about the mechanism of how <i>C. cicadae</i> polysaccharide (CCP) might improve diabetic conditions. <b>Methods:</b> This study investigated its effects on the intestinal microbiota, intestinal mucosal barrier, and inflammation in mice with type 2 diabetes mellitus (T2DM) induced by streptozotocin, and its potential mechanisms. <b>Results:</b> Compared with the DC (diabetes model control group), CCPH oral treatment significantly increased the number of beneficial bifidobacteria, bifidobacteria, and lactobacilli (<i>p</i> < 0.01), restored the diversity of intestinal microorganisms in diabetic mice, and the proportions of Firmicutes and Bacteroidetes (34.36%/54.65%) were significantly lower than those of the DC (52.15%/32.09%). Moreover, CCPH significantly reduced the content of endotoxin (lipopolysaccharide, LPS) and D-lactic acid(D-LA) (<i>p</i> < 0.05), the activities of antioxidant enzymes and total antioxidant capacity were significantly increased (<i>p</i> < 0.01), and the content of proinflammatory cytokines TNF-α, IL-6, and IL-1β were reduced by 42.05%, 51.28%, and 52.79%, respectively, compared with the DC. The TLR4/NF-κB signaling pathway, as a therapeutic target for diabetic intestinal diseases, plays a role in regulating the inflammatory response and protecting the intestinal barrier function. Molecular mechanism studies showed that oral treatment with CCPH down-regulated the expression of NF-κB, TLR-4, and TNF-α genes by 18.66%, 21.58%, and 34.87%, respectively, while up-regulating the expression of ZO-1 and occludin genes by 32.70% and 25.11%, respectively. CCPH regulates the expression of short-chain fatty acid levels, increases microbial diversity, and ameliorates mouse colon lesions by inhibiting the TLR4/NF-κB signaling pathway. <b>Conclusions:</b> In conclusion, it is demonstrated that in this murine model, the treatment of diabetes with <i>C. cicadae</i> polysaccharide can effectively regulate intestinal microbiota imbalance, protect intestinal mucosal barrier function, and reduce inflammation in vivo, suggesting this natural product can provide a suitable strategy for the treatment of T2D-induced gut dysbiosis and intestinal health.
format Article
id doaj-art-3855b775bc794ac0910f3c7e4eb429f7
institution Kabale University
issn 2218-1989
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj-art-3855b775bc794ac0910f3c7e4eb429f72025-01-24T13:41:08ZengMDPI AGMetabolites2218-19892025-01-01151810.3390/metabo15010008Effects of <i>Cordyceps cicadae</i> Polysaccharide on Gut Microbiota, the Intestinal Mucosal Barrier, and Inflammation in Diabetic MiceLijia Sun0Huaibo Yuan1Huiqing Ma2Yani Wang3School of Food and Biological Engineering, Hefei University of Technology, No. 193, Tunxi Road, Hefei 230009, ChinaSchool of Food and Biological Engineering, Hefei University of Technology, No. 193, Tunxi Road, Hefei 230009, ChinaSchool of Food and Biological Engineering, Hefei University of Technology, No. 193, Tunxi Road, Hefei 230009, ChinaSchool of Food and Biological Engineering, Hefei University of Technology, No. 193, Tunxi Road, Hefei 230009, China<b>Background:</b> Polysaccharides produced by the edible fungus <i>Cordyceps cicadae</i> can regulate blood sugar levels and may represent a suitable candidate for the treatment of diabetes and its complications. However, there is limited information available about the mechanism of how <i>C. cicadae</i> polysaccharide (CCP) might improve diabetic conditions. <b>Methods:</b> This study investigated its effects on the intestinal microbiota, intestinal mucosal barrier, and inflammation in mice with type 2 diabetes mellitus (T2DM) induced by streptozotocin, and its potential mechanisms. <b>Results:</b> Compared with the DC (diabetes model control group), CCPH oral treatment significantly increased the number of beneficial bifidobacteria, bifidobacteria, and lactobacilli (<i>p</i> < 0.01), restored the diversity of intestinal microorganisms in diabetic mice, and the proportions of Firmicutes and Bacteroidetes (34.36%/54.65%) were significantly lower than those of the DC (52.15%/32.09%). Moreover, CCPH significantly reduced the content of endotoxin (lipopolysaccharide, LPS) and D-lactic acid(D-LA) (<i>p</i> < 0.05), the activities of antioxidant enzymes and total antioxidant capacity were significantly increased (<i>p</i> < 0.01), and the content of proinflammatory cytokines TNF-α, IL-6, and IL-1β were reduced by 42.05%, 51.28%, and 52.79%, respectively, compared with the DC. The TLR4/NF-κB signaling pathway, as a therapeutic target for diabetic intestinal diseases, plays a role in regulating the inflammatory response and protecting the intestinal barrier function. Molecular mechanism studies showed that oral treatment with CCPH down-regulated the expression of NF-κB, TLR-4, and TNF-α genes by 18.66%, 21.58%, and 34.87%, respectively, while up-regulating the expression of ZO-1 and occludin genes by 32.70% and 25.11%, respectively. CCPH regulates the expression of short-chain fatty acid levels, increases microbial diversity, and ameliorates mouse colon lesions by inhibiting the TLR4/NF-κB signaling pathway. <b>Conclusions:</b> In conclusion, it is demonstrated that in this murine model, the treatment of diabetes with <i>C. cicadae</i> polysaccharide can effectively regulate intestinal microbiota imbalance, protect intestinal mucosal barrier function, and reduce inflammation in vivo, suggesting this natural product can provide a suitable strategy for the treatment of T2D-induced gut dysbiosis and intestinal health.https://www.mdpi.com/2218-1989/15/1/8<i>Cordyceps cicadae</i> polysaccharidesdiabetes mellitusintestinal floraintestinal mucosal barrierinflammation
spellingShingle Lijia Sun
Huaibo Yuan
Huiqing Ma
Yani Wang
Effects of <i>Cordyceps cicadae</i> Polysaccharide on Gut Microbiota, the Intestinal Mucosal Barrier, and Inflammation in Diabetic Mice
Metabolites
<i>Cordyceps cicadae</i> polysaccharides
diabetes mellitus
intestinal flora
intestinal mucosal barrier
inflammation
title Effects of <i>Cordyceps cicadae</i> Polysaccharide on Gut Microbiota, the Intestinal Mucosal Barrier, and Inflammation in Diabetic Mice
title_full Effects of <i>Cordyceps cicadae</i> Polysaccharide on Gut Microbiota, the Intestinal Mucosal Barrier, and Inflammation in Diabetic Mice
title_fullStr Effects of <i>Cordyceps cicadae</i> Polysaccharide on Gut Microbiota, the Intestinal Mucosal Barrier, and Inflammation in Diabetic Mice
title_full_unstemmed Effects of <i>Cordyceps cicadae</i> Polysaccharide on Gut Microbiota, the Intestinal Mucosal Barrier, and Inflammation in Diabetic Mice
title_short Effects of <i>Cordyceps cicadae</i> Polysaccharide on Gut Microbiota, the Intestinal Mucosal Barrier, and Inflammation in Diabetic Mice
title_sort effects of i cordyceps cicadae i polysaccharide on gut microbiota the intestinal mucosal barrier and inflammation in diabetic mice
topic <i>Cordyceps cicadae</i> polysaccharides
diabetes mellitus
intestinal flora
intestinal mucosal barrier
inflammation
url https://www.mdpi.com/2218-1989/15/1/8
work_keys_str_mv AT lijiasun effectsoficordycepscicadaeipolysaccharideongutmicrobiotatheintestinalmucosalbarrierandinflammationindiabeticmice
AT huaiboyuan effectsoficordycepscicadaeipolysaccharideongutmicrobiotatheintestinalmucosalbarrierandinflammationindiabeticmice
AT huiqingma effectsoficordycepscicadaeipolysaccharideongutmicrobiotatheintestinalmucosalbarrierandinflammationindiabeticmice
AT yaniwang effectsoficordycepscicadaeipolysaccharideongutmicrobiotatheintestinalmucosalbarrierandinflammationindiabeticmice